Don’t miss our top 5 cancer-related stories this month, including a guest commentary from an industry leader, our two-part series on trends in cancer research and more!
 
Revolutionizing and personalizing global health 
By E. Kevin Hrusovsky, PerkinElmer Inc.
As the complexity and volume of data continue to rise, bioinformatics is emerging as one of the cornerstones of personalized medicine, from enabling discovery and development of novel treatments and diagnostics to facilitating collection, analysis and interpretation of data that ultimately helps an individual patient.  

SPECIAL REPORT PART 1: ‘Good enough’ is no longer good enough 
By Randall Willis, ddn Features Editor
Aiming beyond the standard of care in oncology  

SPECIAL REPORT PART 2: An aside on side effects 
By Randall Willis, ddn Features Editor
Are we really making things better for cancer patients?  

High-profile oncology partnership
By Jim Cirigliano, ddn Contributing Editor
Araxes Pharma and Janssen Biotech ink oncology drug development deal  

Natural neighbors 
By Kelsey Kaustinen, ddn Features Editor
OSU, Biosortia link up to identify natural products for potential cancer treatments  

 
Hamilton Robotics
 
 
Agios, iNovacia announce new collaboration
March 2012
SHARING OPTIONS:

STOCKHOLM, Sweden—iNovacia AB has announced a high-throughput screening collaboration with Cambridge, Mass.-based Agios Pharmaceuticals, a company focusing on cancer metabolism. Per the terms of the agreement, iNovacia will provide small-molecule lead generation services for the collaboration in addition to identifying modulators of pharmaceutical targets of interest to Agios through use of iNovacia’s proprietary screening library. Financial details for the collaboration were not disclosed.
 
“We have had successful screening projects with Agios in the past and we are now proud to be able to extend this relationship,” Dr. Thomas Olin, CEO of iNovacia, said in a press release. “We are pleased that Agios and other U.S. and European companies continue to appreciate the value of our premium screening operations and proprietary screening library as a means to generate high-quality chemistry starting points.”

Back

BioSearch


Beckman

ISSCR

eBiosciences

Tecan
CONTACT US
Drug Discovery News
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
nanoString
© Copyright 2013 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.